Thermo Fisher Plunges 2.43% as $740M Volume Ranks 114th Amid Sector Rotation

, 2025, , . equities. The decline came despite its position in the top 100 most actively traded stocks for the day, highlighting mixed investor sentiment.

Recent market activity reflects broader sector rotation rather than company-specific catalysts. The biotech and life sciences equipment sector faced broad-based profit-taking following a multi-week rally, . Institutional selling pressure emerged in the latter half of the session, contributing to the downward momentum.

Analyst coverage remains cautiously optimistic, . However, recent FDA guidance on diagnostic device approvals has created regulatory uncertainty for the sector, tempering near-term growth expectations. , suggesting bearish positioning among active traders.

For the backtesting analysis: A strategy selecting the top 500 U.S. stocks by daily dollar volume would require constructing and liquidating a basket each trading day. Current tools limit this to single-asset testing, but alternative approaches include using broad-market ETFs as proxies or building custom data pipelines to track volume-based signals. Implementation timelines vary depending on data complexity and processing requirements.